drugset / Trial / NCT06035406
A Trial of SP2086 With Hepatic Insufficiency
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study used a single-dose, open design to compare the pharmacokinetics of subjects with mild and moderate liver impairment and subjects with normal liver function.
Timeline
- Start
- 2023-09
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Retagliptin | Small molecule | 100 mg | — |